| Vaccine Therapy in Treating Patients With Metastatic Breast Cancer (NCT00003761) | Dana-Farber Cancer Institute | 1999-03-03 |
| Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00005627) | Dana-Farber Cancer Institute | 1999-03-01 |
| Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery (NCT00003744) | Dana-Farber Cancer Institute | 1998-11-01 |
| Tangential Radiation Therapy Without Axillary Dissection in Breast Cancer (NCT00165243) | Dana-Farber Cancer Institute | 1998-09-01 |
| Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus (NCT00165191) | Dana-Farber Cancer Institute | 1998-08-01 |
| Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing (NCT00165152) | Dana-Farber Cancer Institute | 1998-07-01 |
| High-dose ICE With Amifostine (NCT00003657) | Dana-Farber Cancer Institute | 1998-07-01 |
| A-protein Levels in Adult and Pediatric Brain Tumor Patients (NCT00165542) | Dana-Farber Cancer Institute | 1998-06-01 |
| Study of Docetaxel in Combination With Cisplatin and 5-Fluorouracil in Locally Advanced Squamous Cell Carcinoma of the Head and Neck (NCT00139269) | Dana-Farber Cancer Institute | 1998-02-01 |
| Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer (NCT00251355) | Dana-Farber Cancer Institute | 1998-01-01 |
| Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck (NCT00139243) | Dana-Farber Cancer Institute | 1997-10-01 |
| Troglitazone in Treating Patients With Liposarcoma (NCT00003058) | Dana-Farber Cancer Institute | 1997-06-01 |
| A Study of All-Trans Retinoic Acid (ATRA) and Bryostatin in Patients With Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) (NCT00136461) | Dana-Farber Cancer Institute | 1997-05-01 |
| Hyperthermia Plus Radiation Therapy in Treating Patients With Nonmetastatic Advanced Prostate Cancer (NCT00003045) | Dana-Farber Cancer Institute | 1997-04-01 |
| Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (NCT00139230) | Dana-Farber Cancer Institute | 1997-01-01 |
| Treatment of Childhood Acute Lymphoblastic Leukemia (NCT00165087) | Dana-Farber Cancer Institute | 1996-01-01 |
| Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas (NCT00165139) | Dana-Farber Cancer Institute | 1996-01-01 |
| Chemotherapy Plus Radiation Therapy in Treating Patients With Squamous Cell Cancer of the Head and Neck (NCT00003200) | Dana-Farber Cancer Institute | 1995-10-01 |
| Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer (NCT00116220) | Dana-Farber Cancer Institute | 1995-09-01 |
| Wide Excision Alone as Treatment for Ductal Carcinoma in Situ of The Breast (NCT00165256) | Dana-Farber Cancer Institute | 1995-05-15 |
| Multicenter Study of 9-Aminocamptothecin (9-AC) in Patients With Refractory Leukemia (NCT00251368) | Dana-Farber Cancer Institute | 1995-01-01 |
| High Dose Ara-C (HDAC) and Interleukin-2 (IL-2) for Patients With Acute Myelogenous Leukemia (AML) (NCT00136448) | Dana-Farber Cancer Institute | 1993-02-01 |
| Mantle Irradiation for Hodgkin's Disease (NCT00165269) | Dana-Farber Cancer Institute | 1992-05-01 |
| Early Patient Access Single Named Patient Program for the Use of Ulocuplumab for the Treatment of Multiple Myeloma (NCT02666209) | Dana-Farber Cancer Institute | |
| GO-203-2C + Bortezomib For Relapsed Or Refractory MM (NCT02658396) | Dana-Farber Cancer Institute | |
| MK-2206 for Recurrent Malignant Glioma (NCT01249105) | Dana-Farber Cancer Institute | |
| Clofarabine for Langerhans in Pedi (NCT01796405) | Dana-Farber Cancer Institute | |
| OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas (NCT01600807) | Dana-Farber Cancer Institute | |